West Oak Capital, LLC Biogen Inc. Transaction History

West Oak Capital, LLC

$2.83 Billion
Q4 2024

A detailed history of West Oak Capital, LLC transactions in Biogen Inc. stock. As of the latest transaction made, West Oak Capital, LLC holds 45 shares of BIIB stock, worth $6,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 945 95.24%

Holding current value

$6,340

Previous $69,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$146.47 - $191.55 $131,823 - $172,395	-900 Reduced 95.24%	45 $69,000
Q4 2024 Jan 10, 2025	BUY	$146.47 - $191.55 $131,823 - $172,395	900 Added 2000.0%	945 $69,000
Q3 2024 Oct 17, 2024	SELL	$189.07 - $236.8 $189 - $236	-1 Reduced 2.17%	45 $87,000
Q4 2019 Jan 09, 2020	SELL	$220.06 - $304.07 $38,510 - $53,212	-175 Reduced 79.19%	46 $14,000
Q2 2019 Jul 12, 2019	SELL	$219.29 - $241.72 $1 Million - $1.1 Million	-4,571 Reduced 95.39%	221 $52,000
Q1 2019 Apr 03, 2019	SELL	$216.71 - $338.96 $2,167 - $3,389	-10 Reduced 0.21%	4,792 $1.13 Million
Q4 2018 Jan 08, 2019	BUY	$278.5 - $352.75 $50,687 - $64,200	182 Added 3.94%	4,802 $1.45 Billion
Q3 2018 Oct 04, 2018	BUY	$293.51 - $383.83 $9,392 - $12,282	32 Added 0.7%	4,620 $1.63 Billion
Q2 2018 Jul 06, 2018	SELL	$257.52 - $306.91 $6,438 - $7,672	-25 Reduced 0.54%	4,588 $1.33 Billion
Q1 2018 Apr 05, 2018	BUY	$260.13 - $367.91 $1,560 - $2,207	6 Added 0.13%	4,613 $1.26 Billion
Q4 2017 Jan 05, 2018	SELL	$307.64 - $344.58 $26,764 - $29,978	-87 Reduced 1.85%	4,607 $1.47 Billion
Q3 2017 Oct 10, 2017	BUY	$281.15 - $329.69 $1.32 Million - $1.55 Million	4,694	4,694 $1.47 Billion

Others Institutions Holding BIIB

# of Institutions

1,007

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Account

West Oak Capital, LLC Biogen Inc. Transaction History